Literature DB >> 2360256

Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones.

K Matsumoto1, J Yamamoto, M Hiraiwa, K Kano, M Takiguchi.   

Abstract

Human CTL clones discriminating serologically closely related HLA-Bw52, B51, and B35, which belong to HLA-B5 crossreacting group (CREG), were established from peripheral blood lymphocytes by repeated in vitro stimulations. Five HLA-Bw52-specific CTL clones from an individual with HLA-B5 CREG antigens and four CTL clones from another individual with HLA-B51 were generated. The specificity of these CTL clones was ascertained by their lysis of EBV-transformed B cells with HLA-Bw52, but not those with HLA-B51 or B35, and Bw52-transfected Hmy2CIR cells but not HLA-B51 or B35 transfectants. Conversely HLA-B51-specific clones were generated from the HLA-B5 CREG-negative individual, as well as another individual with HLA-Bw52. Their specificity was determined in a similar fashion. Since HLA-B51 differed from HLA-Bw52 only by two amino acid substitutions on the alpha helical region of the alpha 1 domain, these results demonstrated that allospecific CTLs can be produced and discriminate the epitopes formed by the subtle difference in the structure of these HLA class I molecules. Furthermore, three HLA-B35-specific CTL clones were generated from the HLA-B5 CREG-negative individual that discriminated HLA-B35 from HLA-Bw52 and B51. Taken together these results demonstrated that human CTL clones could definitively discriminate the three serologically related HLA-B5 CREG specificities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360256     DOI: 10.1097/00007890-199006000-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101.

Authors:  Yuka Kawashima; Nozomi Kuse; Hiroyuki Gatanaga; Takuya Naruto; Mamoru Fujiwara; Sachi Dohki; Tomohiro Akahoshi; Katsumi Maenaka; Philip Goulder; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

2.  Two amino acid substitutions at residues 63 and 67 between HLA-B51 and HLA-Bw52 form multiple epitopes recognized by allogeneic T cells.

Authors:  J Yamamoto; M Hiraiwa; H Hayashi; M Tanabe; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket.

Authors:  A Kikuchi; T Sakaguchi; K Miwa; Y Takamiya; H G Rammensee; Y Kaneko; M Takiguchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Molecular analysis of HLA-B39 subtypes.

Authors:  N Kato; S Karaki; K Kashiwase; C Müller; T Akaza; T Juji; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Two subtypes of HLA-B51 differing by substitution at position 171 of the alpha 2 helix.

Authors:  G Kawaguchi; W H Hildebrand; M Hiraiwa; S Karaki; T Nagao; N Akiyama; H Uchida; K Kashiwase; T Akaza; R C Williams
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.